Source: Annual Congress 2009 - Respiratory physiology
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Celebi Sozener, G. Karabiyikoglu, N. Duzgun (Ankara, Turkey). Evaluation of the functional parameters in scleroderma cases with pulmonary involvement. Eur Respir J 2009; 34: Suppl. 53, 3506

Member's Comments

No comment yet.

Related content which might interest you: Clinical and laboratory features of systemic sclerosis with pulmonary involvement Source: Eur Respir J 2001; 18: Suppl. 33, 512s Year: 2001 Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease Source: Eur Respir Rev, 27 (148) 170102; 10.1183/16000617.0102-2017 Year: 2018 Change in pulmonary function abnormalities in sarcoidosis over time: A review of 75 cases Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012 Correlation among pulmonary function tests and radiologic involvement in the monitoring of sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Significance of pulmonary involvement in systemic sclerosis (SSc)– data from the German SSc-network Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Assessment of cardiac involvement in patients with sarcoidosis Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Comprehensive evaluation of airway involvement in pulmonary sarcoidosis Source: ERJ Open Res, 3 (1) 00105-2016; 10.1183/23120541.00105-2016 Year: 2017 Study of the system of hemostasis in patients with chronic forms of pulmonary sarcoidosis (PS) with impairments of regional pulmonary blood circulation Source: Eur Respir J 2006; 28: Suppl. 50, 537s Year: 2006 Ergospirometry findings in patients with scleroderma in relation to concurrent pulmonary hypertension Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases Year: 2010 Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003 Endobronchial findings in pulmonary sarcoidosis and their association with clinical and functional parameters Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Evaluation of specific immune complexes in patients with pulmonary sarcoidosis. Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Angiogenic activity of sera from patients with various types of pulmonary fibrosis in relation to pulmonary functions Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Clinical and radiological variants of fibrosis pulmonary sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020 Features of pulmonary involvement in patients with diffuse connective tissue diseases Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Effects of lymphadenopathy on pulmonary function tests in sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Renal involvement in chronic pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 550s Year: 2005 Hemodynamic phenotypes in systemic sclerosis patients screened for pulmonary hypertension – impact of the new PH-definition Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019